Evidence map›Paper›PMID 41373484›Full record

ArticleInternational journal of molecular sciences2025

Profiling of CD63 and EpCAM Membrane Proteins of Extracellular Vesicles on Tannic Acid-Coated Magnetic Beads Using Conventional Flow Cytometry.

Ekaterina Moiseeva, Igor Sergeev, Vasiliy Chernyshev, Olga Zaborova, Daria Kohzevnikova, Alexander Yakovlev, Olesya Kuznetsova, Alexey Tryakin, Aleksei Komlev, Dmitry Gorin and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ekaterina MoiseevaSkolkovo Institute of Science and Technology, Skolkovo Innovation Center, 121205 Moscow, Russia.ORCID 0000-0002-0703-0208
Igor SergeevSkolkovo Institute of Science and Technology, Skolkovo Innovation Center, 121205 Moscow, Russia.ORCID 0000-0001-8267-4647
Vasiliy ChernyshevSkolkovo Institute of Science and Technology, Skolkovo Innovation Center, 121205 Moscow, Russia.ORCID 0000-0003-2372-7037
Olga ZaborovaFaculty of Chemistry, Moscow State University, 119991 Moscow, Russia.ORCID 0000-0003-1646-9981
Daria KohzevnikovaSkolkovo Institute of Science and Technology, Skolkovo Innovation Center, 121205 Moscow, Russia.ORCID 0009-0002-0959-8152
Alexander YakovlevMoscow Research and Clinical Center for Neuropsychiatry, 115419 Moscow, Russia.ORCID 0000-0003-2546-5130
Olesya KuznetsovaN.N. Blokhin National Medical Research Center of Oncology, 115522 Moscow, Russia.
Alexey TryakinN.N. Blokhin National Medical Research Center of Oncology, 115522 Moscow, Russia.ORCID 0000-0003-2245-214X
Aleksei KomlevFaculty of Physics, Moscow State University, 119991 Moscow, Russia.ORCID 0000-0003-4319-3781
Dmitry GorinSkolkovo Institute of Science and Technology, Skolkovo Innovation Center, 121205 Moscow, Russia.
Alexey YashchenokSkolkovo Institute of Science and Technology, Skolkovo Innovation Center, 121205 Moscow, Russia.ORCID 0000-0002-8302-5646

Funding

Russian Science Foundation 23-74-00022
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are considered to be a promising tool in disease diagnosis. However, the clinical translation of EV-based liquid biopsy faces significant challenges due to the lack of inexpensive, rapid, and high-throughput methods of EV analysis. Bead-based platforms, combined with conventional flow cytometry, allow for the simultaneous capture and immunolabeling of EVs. In this study, we present a new approach based on the label-free isolation of EVs by tannic acid-coated superparamagnetic beads (TASPMB) combined with immunofluorescence detection of EV membrane proteins using flow cytometry. First, we tested the molecular profiling capabilities of the approach using EVs derived from human breast and colorectal cancer cell lines and from plasma of colorectal cancer patients to recognize the tetraspanin protein CD63 and the epithelial cell adhesion molecule (EpCAM). Subsequently, the developed approach was validated to identify proteins on EVs enriched with TASPMB from the conditioned media of SKBR3 and HT29 cell cultures without preliminary purification by a size-exclusion chromatography (SEC) column. The developed approach demonstrates a high capacity for isolating EVs and subsequently profiling of their membrane proteins, with a total assay time of approximately 2 h. The approach presented here can be a promising tool for rapid detection of EV membrane proteins using conventional instruments, such as flow cytometry.

Indexed as

Epithelial Cell Adhesion MoleculeExtracellular VesiclesFlow CytometryTanninsTetraspanin 30Breast NeoplasmsCell Line, TumorColorectal NeoplasmsHT29 CellsHumansMembrane ProteinsPolyphenolsCD63 protein, humanEPCAM protein, humanEpithelial Cell Adhesion MoleculeMembrane ProteinsPolyphenolstannic acidTanninsTetraspanin 30cancer diagnosticsexosomesliquid biopsysmall extracellular vesiclessuperparamagnetic beads

Identifiers

PMID41373484
PMCPMC12692446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.